{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:00:22Z","timestamp":1761170422608,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.hjc.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T01:51:00Z","timestamp":1553133060000},"page":"256-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and efficacy of global intracoronary administration of cardiosphere-derived cells or conditioned medium immediately after\u00a0coronary reperfusion in rats"],"prefix":"10.1016","volume":"61","author":[{"given":"Styliani","family":"Vakrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Nana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis A.","family":"Nanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmeleia","family":"Nana-Leventaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bonios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Kapelios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hjc.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur Heart J"},{"issue":"42","key":"10.1016\/j.hjc.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hjc.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","article-title":"Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications","volume":"81","author":"Pfeffer","year":"1990","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hjc.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.115.307347","article-title":"Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies: Controversies in Meta-Analyses Results on Cardiac Cell-Based Regenerative Studies","volume":"118","author":"Gyongyosi","year":"2016","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.hjc.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","article-title":"Cardiomyocyte Regeneration: A Consensus Statement","volume":"136","author":"Eschenhagen","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hjc.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/clpt.2011.175","article-title":"The stuttering progress of cell therapy for heart disease","volume":"90","author":"Malliaras","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.hjc.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.116.027039","article-title":"Is Cardioprotection Dead?","volume":"136","author":"Lefer","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hjc.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/emmm.201201737","article-title":"Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart","volume":"5","author":"Malliaras","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.hjc.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","article-title":"Mechanisms of mesenchymal stem\/stromal cell function","volume":"7","author":"Spees","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.hjc.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/emmm.201303626","article-title":"Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction","volume":"6","author":"Malliaras","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.hjc.2019.03.001_bib11","first-page":"Cd006536","article-title":"Stem cell treatment for acute myocardial infarction","author":"Fisher","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"10.1016\/j.hjc.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"Jama"},{"issue":"9819","key":"10.1016\/j.hjc.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hjc.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.hjc.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.09.001","article-title":"Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment","volume":"73","author":"Chan","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.hjc.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.hjc.2016.11.036","article-title":"A\u00a0combined cellular and surgical ventricular reconstruction therapeutic approach produces attenuation of remodeling in infarcted rats","volume":"58","author":"Bonios","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2019.03.001_bib17","article-title":"Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis","author":"Nana-Leventaki","year":"2018","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.hjc.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hjc.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection","volume":"113","author":"Botker","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hjc.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2016.09.011","article-title":"Cardioprotective effects of intracoronary administration of 4-chlorodiazepam in small and large animal models of ischemia-reperfusion","volume":"224","author":"Tsamatsoulis","year":"2016","journal-title":"Int J Cardiol"},{"issue":"17","key":"10.1016\/j.hjc.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2009.04.097","article-title":"Noninvasive quantification and optimization of acute cell retention by in\u00a0vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery","volume":"54","author":"Terrovitis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2019.03.001_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCULATIONAHA.111.042598","article-title":"Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells","volume":"125","author":"Malliaras","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hjc.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCHEARTFAILURE.114.001484","article-title":"Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction","volume":"8","author":"Kanazawa","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.hjc.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration - lessons learned and future directions","volume":"15","author":"Menasche","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.hjc.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hjc.2019.03.001_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ahj.2011.08.002","article-title":"Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial","volume":"162","author":"Kelly","year":"2011","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hjc.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00330-010-1963-8","article-title":"Time course of infarct healing and left ventricular remodelling in patients with reperfused ST segment elevation myocardial infarction using comprehensive magnetic resonance imaging","volume":"21","author":"Ganame","year":"2011","journal-title":"Eur Radiol"},{"issue":"47","key":"10.1016\/j.hjc.2019.03.001_bib28","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hjc.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.hjc.2019.03.001_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hjc.2019.03.001_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/cvr\/cvy222","article-title":"Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug","volume":"115","author":"Bibli","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.hjc.2019.03.001_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hjc.2019.03.001_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00395-006-0615-2","article-title":"The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion","volume":"101","author":"Reffelmann","year":"2006","journal-title":"Basic Res Cardiol"},{"issue":"24","key":"10.1016\/j.hjc.2019.03.001_bib34","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","article-title":"Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention","volume":"117","author":"Jaffe","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hjc.2019.03.001_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hjc.2017.12.009","article-title":"Pharmacologic inhibition of the mitochondrial Na(+)\/Ca(2+) exchanger protects against ventricular arrhythmias in a porcine model of ischemia-reperfusion","volume":"59","author":"Sventzouri","year":"2018","journal-title":"Hellenic J Cardiol"},{"issue":"6","key":"10.1016\/j.hjc.2019.03.001_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41551-018-0216-z","article-title":"A\u00a0mechanistic roadmap for the clinical application of cardiac cell therapies","volume":"2","author":"Marb\u00e1n","year":"2018","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"10.1016\/j.hjc.2019.03.001_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096368916X692933","article-title":"ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design","volume":"26","author":"Chakravarty","year":"2017","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1016\/j.hjc.2019.03.001_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.scr.2011.01.001","article-title":"Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction","volume":"6","author":"Timmers","year":"2011","journal-title":"Stem Cell Res"},{"issue":"10","key":"10.1016\/j.hjc.2019.03.001_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hjc.2019.03.001_bib41","doi-asserted-by":"crossref","first-page":"H2766","DOI":"10.1152\/ajpheart.2000.279.6.H2766","article-title":"Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats","volume":"279","author":"Zhai","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:13:30Z","timestamp":1761099210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966618305645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1109966618305645"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2019.03.001","relation":{},"ISSN":["1109-9666"],"issn-type":[{"type":"print","value":"1109-9666"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of global intracoronary administration of cardiosphere-derived cells or conditioned medium immediately after\u00a0coronary reperfusion in rats","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}